Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Parameter trajectory analysis to identify treatment effects of pharmacological interventions.

PLoS computational biology - 1 Jan 2013

Tiemann Christian A, Vanlier Joep, Oosterveer Maaike H, Groen Albert K, Hilbers Peter A J, van Riel Natal A W

Abstract excerpt

The field of medical systems biology aims to advance understanding of molecular mechanisms that drive disease progression and to translate this knowledge into therapies to effectively treat diseases. A challenging task is the investigation of long-term effects of a (pharmacological) treatment, to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, HDL
Share to Drug Therapy
Share to Lipoproteins, VLDL

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver X Receptors

Share to Monte Carlo Method

Share to Orphan Nuclear Receptors

Share to Sulfonamides

Share to Triglycerides

Source

Open in PubMed Open full text

Identifiers

PMID: 23935478
DOI: 10.1371/journal.pcbi.1003166
PMCID: PMC3731221

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23935478-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Parameter trajectory analysis to identify treatment effects of pharmacological interventions.PMID 23935478Read ↗

Parameter adaptations during phenotype transitions in progressive diseases.Semantic proximity Read ↗

Mechanistic systems modeling to guide drug discovery and development.Semantic proximity Read ↗

Computational modelling of atherosclerosis: developing a community resourceSemantic proximity Read ↗

A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding.Semantic proximity Read ↗

Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemiaSemantic proximity Read ↗

M4 drug discovery: human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonistSemantic proximity Read ↗

A physiology-based model of bile acid metabolism shows altered tissue concentrations after drug administration and in specific genotype subgroupsSemantic proximity Read ↗

Adaptive receptor expression and the emergence of disease as loss of signaling homeostasisSemantic proximity Read ↗

A system perspective on drug response.Semantic proximity Read ↗

Estimating the Effects of Treatment Regimes over the Course of Chronic Disease: A Multi-state Causal Framework with Baseline ConfoundingSemantic proximity Read ↗

Systems Pharmacology Dissection of Cholesterol Regulation Reveals Determinants of Large Pharmacodynamic Variability between Cell Lines.Semantic proximity Read ↗

In silico dynamic molecular interaction networks for the discovery of new therapeutic targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.